Mei-Lang Kung | Pharmacology | Women Researcher Award

Posted on by Forensic Scientist

Assist. Prof. Dr. Mei-Lang Kung | Pharmacology | Women Researcher Award

Senior Assistant Research Fellow | Kaohsiung Veterans General Hospital | Taiwan

Dr. Mei-Lang Kung is a distinguished researcher and academic specializing in cancer biology, gene engineering, and phytochemical pharmacology. She currently serves as a Senior Assistant Research Fellow at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital, and an Assistant Professor at Shu-Zen Junior College of Medicine and Management. With a strong background in molecular biology and nanomedicine, Dr. Kung has contributed significantly to innovative research in oncology and nanomaterials for medical applications.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background 📚

    • Dr. Mei-Lang Kung holds a Ph.D. in Biological Science from National Sun Yat-sen University (2012).
    • Her dissertation focused on cancer cell migration and epithelial-mesenchymal transition, a highly relevant area in biomedical research.

  • Extensive Research Expertise 🔬

    • Her work spans multiple interdisciplinary fields, including cancer biology, gene engineering, phytochemical pharmacology, and green nanomaterials.
    • These diverse skill sets enhance the impact of her research in translational medicine.

  • Significant Research Contributions 🏆

    • 21+ peer-reviewed publications in high-impact journals (SCI-indexed).
    • Notable research on nanomedicine and cancer treatment strategies, contributing to innovative therapeutic approaches.
    • Demonstrated leadership as a corresponding author in multiple studies, reflecting independent research capability.

  • Recognition & Awards 🥇

    • Best Poster Award (2021) from the Taiwan Urology Association.
    • National Taiwan University System Young Scholars Award (2018) for innovative research.
    • Multiple Outstanding Paper Awards at prestigious conferences (IEEE, New Advance in Medicine, etc.).
    • These accolades highlight her excellence in research and scholarly impact.

Education 🎓

Dr. Kung earned her Ph.D. in Biological Science from National Sun Yat-sen University, Kaohsiung, Taiwan, in 2012, under the guidance of Prof. Tai Ming-Hong. Her dissertation focused on the mechanisms of hepatoma-derived growth factor-mediated cell migration and epithelial-mesenchymal transition. She also holds an M.S. in Biochemistry from Kaohsiung Medical University (2002) and a B.S. in Nutrition from Chung Shan Medical University (2000).

Experience 🌟

Dr. Kung has extensive experience in academia and research. Since 2019, she has been a Senior Assistant Research Fellow at Kaohsiung Veterans General Hospital. She also holds a faculty position at Shu-Zen Junior College of Medicine and Management. Previously, she served as an Assistant Faculty member (2017-2019) and a Postdoctoral Research Associate (2012-2017) in the Chemistry Department of National Sun Yat-sen University, working under Dr. Shuchen Hsieh.

Research Interests On Pharmacology 📚

Dr. Kung’s research interests include cancer biology, gene engineering, phytochemical pharmacology, and toxicology. She is particularly focused on the development and applications of green nanomaterials for cancer treatment. Her work explores novel phytochemically derived nanoparticles and their effects on cancer cell adhesion, proliferation, and metastasis.

Awards 🏆

  • 2021: Taiwan Urology Association “Best Academic Activity Award – Best Poster Award”
  • 2018: National Taiwan University System Young Scholars Selection for Innovative Research and Development Achievements – Excellent Work Award
  • 2015: New Advance in Generation Medicine, Cancer and Stem Cell Outstanding Paper Award
  • 2013: IEEE Nanotechnology Materials and Devices Conference, Outstanding Paper Award

Publications 📰

Dr. Kung has authored numerous peer-reviewed publications in high-impact journals. Below are some of her notable works:

  1. Wang, J.-H., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2025). “Nanosized ginger-derived phenolic zingerone obstructs cell cycle G2/M progression and initiates apoptosis in human colorectal cancer.” Environmental Toxicology. DOI:10.1002/tox.24470 (SCI; 2023 IF=4.4)
  2. Chu, L.-W., Chen, J.-Y., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2024). “Phytoconstituent-derived zingerone nanoparticles disrupt cell adhesion and suppress cell motility in melanoma B16F10 cells.” Journal of Biotechnology. DOI:10.1016/j.jbiotec.2024.06.015
  3. Kung, M.-L., Cheng, S. M., Wang, Y.-H., et al.* (2024). “Deficiency of RNA adenosine deaminase (ADAR2) ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in male diet-induced obese mice.” Communications Biology. (SCI; 2022 IF=5.9)
  4. Kung, M.-L., Yang, T.-H., Lin, C.-C., et al.* (2024). “ADAR2 deficiency ameliorates nonalcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.” Journal of Cachexia, Sarcopenia and Muscle. DOI:10.1002/jcsm.13460 (SCI; 2022 IF=8.9)
  5. Hu, T.-H., Wu, J.-C., Huang, S.-T., et al.* (2023). “HDGF Stimulates Liver Tumorigenesis by Enhancing Reactive Oxygen Species Generation in Mitochondria.” Journal of Biological Chemistry. (SCI; 2022 IF=4.8)

Conclusion 📚

Dr. Mei-Lang Kung has made remarkable contributions to cancer research and nanomedicine, with a strong emphasis on translating scientific discoveries into therapeutic applications. Her expertise in molecular oncology and green nanotechnology continues to impact the scientific community, making her a leader in the field of biomedical research. Through her innovative work, she strives to advance cancer treatment strategies and improve patient outcomes.

latifa khattabi | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Dr. latifa khattabi | Pharmacology | Best Researcher Award

senior researcher | National Biotechnology Research Center | Algeria

Dr. Latifa Khattabi is a passionate and accomplished Permanent Researcher at the Biotechnology Research Center (CRBt) in Constantine, Algeria. Born on November 3, 1990, in El Khroub, Constantine, she has dedicated her career to the field of molecular and cellular immunology. Known for her excellence, perseverance, and ambition, Dr. Khattabi has contributed significantly to the advancement of scientific research, particularly in antioxidant, anti-inflammatory, and pharmacological studies.

Profile

Orcid

Strengths for the Awards

  • Academic Excellence:
    • Achieved a PhD in “Molecular and Cellular Immunology” (2023) and was recognized as an “Excellent Student” during her undergraduate and master’s studies.
    • Comprehensive education in immunology, oncology, and biochemistry demonstrates strong foundational expertise.
  • Diverse Research Contributions:
    • Published over 22 scientific articles, including as a principal author, in high-impact journals.
    • Research spans across immunology, biochemistry, molecular biology, and toxicology.
    • Significant contributions to topics such as SARS-CoV-2, antioxidant activities, enzyme inhibition, and therapeutic plant derivatives.
  • Research Skills and Expertise:
    • Hands-on experience in advanced techniques, including ELISA, LC-MS/MS, PCR, molecular docking, in vitro and in vivo experiments, and bioinformatics.
    • Multidisciplinary approach integrating immunology, pharmacology, and analytical chemistry.
  • Professional Experience:
    • Over a decade of research at the Biotechnology Research Center (CRBT), where she contributed to innovative projects like camelid antibodies for tuberculosis.
    • Collaborated in projects involving antioxidants, anti-Alzheimer, anti-inflammatory, and antidiabetic activities, reflecting real-world applicability of her research.

Education 🎓

Dr. Khattabi has an impressive academic journey:

  • 2023: PhD in Molecular and Cellular Immunology from University Mentouri Constantine – UMC1.
  • 2013: Master’s Degree in Molecular and Cellular Immunology/Oncology from UMC1, graduating as an excellent student with a dissertation on thyroid cancer.
  • 2011: Bachelor’s Degree in Molecular and Cellular Immunology, also with distinction from UMC1.
  • 2008: Achieved her Baccalaureate in Experimental Sciences.

Experience 🌟

Dr. Khattabi has been a dedicated researcher at CRBt since 2014, excelling in areas such as:

  • Antioxidant, enzymatic, and toxicological assays for pharmacological studies.
  • Molecular biology techniques, including DNA extraction, PCR, and LC-MS/MS analysis.
  • In vivo experiments on animal models, focusing on toxicity and therapeutic effects.
    She is also well-versed in laboratory standards, biosafety protocols, and quality assurance.

Research Interests On Pharmacology 🔬

Her primary research interests include:

  1. Molecular immunology and its applications in oncology.
  2. Pharmacological evaluations, including antioxidant and anti-inflammatory mechanisms.
  3. The toxicological effects of pesticides on health and possible natural remedies.
  4. Epidemiological studies related to cancer and chronic diseases.
  5. Development of rapid diagnostic tools for infectious diseases like SARS-CoV-2.

Awards 🏆

Dr. Khattabi has been recognized for her outstanding contributions:

  • Awarded the Certificate of Excellent Student during her bachelor’s and master’s studies.
  • Nominee for various awards in the field of biotechnology and scientific innovation.

Publications 📚

  • Hydroxyphenylamine Phosphonate Derivatives
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: Journal of Molecular Structure
    • DOI: 10.1016/j.molstruc.2020.129121
    • Citations: Indexed, but specific count not provided​
  • Distribution of Leukocyte Subpopulation Among Students Threatened by Failure
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: International Journal of Research in Pharmaceutical Sciences
    • Citations: Not explicitly listed​
  • Recombinant Protein Targeting and Opsonizing Spike Glycoprotein for Enhancing SARS-CoV-2 Phagocytosis
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: Medical Hypotheses
    • DOI: 10.1016/j.mehy.2020.110108
    • Citations: Indexed but count unavailable​
  • Monomeric and Dimeric Copper (II) Complexes
    • Authors: Khattabi L., et al.
    • Publication Year: 2020
    • Journal: Inorganica Chimica Acta
    • DOI: 10.1016/j.ica.2020.119519
    • Citations: Not specified​
  • Chemical Characterization and Antioxidant Potential of Rosmarinus Tournefortii
    • Authors: Khattabi L., et al.
    • Publication Year: 2019
    • Journal: Journal of Food Measurement and Characterization
    • DOI: 10.1007/s11694-019-00309-y
    • Citations: Not explicitly mentioned​

Conclusion 📝

Dr. Latifa Khattabi stands out as a prolific researcher, dedicated to tackling some of the most pressing challenges in molecular immunology and pharmacology. Her dedication, versatility, and collaborative spirit have cemented her position as a key contributor to the scientific community, both in Algeria and internationally.

Muneeb Ullah | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Mr. Muneeb Ullah | Pharmacology | Best Researcher Award

PhD | University, Busan | South Korea

Muneeb Ullah, a dedicated research assistant in the Department of Pharmacy at Pusan National University in Busan, South Korea, focuses on advancing therapeutic applications of nanotechnology in wound healing. With a strong foundation in Pharmaceutical Sciences from Pakistan, he specializes in innovative nanoparticle-based drug delivery for complex medical conditions, including diabetic and infected wounds.

Profile

 Scopus

Strengths for the Award

  • Academic and Research Background:
    • Muneeb holds advanced degrees in Pharmacy and Pharmaceutical Nanotechnology, with an MPhil focusing on nanoparticle drug delivery systems. This is complemented by hands-on experience as a Research Assistant at reputable institutions, including the Department of Pharmacy at Pusan National University in South Korea.
  • Research Impact and Publications:
    • With over 20 publications, an h-index and i10-index of 8 each, and a total citation count of 296, Muneeb demonstrates substantial academic influence in his field. His publications span high-impact journals and cover areas like wound healing, cancer therapy, and cardiovascular disease management, indicating a commitment to impactful, multidisciplinary research.
    • The research focus on novel therapeutics and nanotechnology is timely and relevant, especially in addressing global health issues like diabetes, wound healing, and cardiovascular diseases.
  • Awards and Recognition:
    • Recognition through awards such as the Higher Education Commission (HEC) Scholarship, Prime Minister Laptop Award, and Best Teacher Award highlight his commitment to academic excellence and education.
  • Technical and Laboratory Skills:
    • Proficiency in advanced laboratory techniques (e.g., nanoparticle preparation, HPLC, cell culturing) and analytical tools (e.g., Endnote, BioRender) positions Muneeb as a well-rounded researcher with essential technical skills.

Education 📚

Muneeb holds an MPhil in Pharmaceutical Sciences with a focus on Nanotechnology from Kohat University of Science and Technology (KUST), Pakistan. He graduated with a first division, gaining deep expertise in pharmaceutics, pharmacology, and biochemistry. His academic journey began with his F.Sc in Pre-Medical and continued with a BS in Pharmacy, both completed with high distinctions. He also possesses specialized skills in advanced research methodologies and analytical techniques.

Experience 💼

Currently, Muneeb serves as a Research Assistant at Pusan National University, contributing to nanoparticle preparation and its applications in wound healing. Previously, he taught at Billitong Higher Secondary School and worked as a Research Assistant at the National University of Medical Sciences, Islamabad. His professional background blends both academia and research, enhancing his practical understanding of nanotechnology in pharmaceutical sciences.

Research Interests 🔬

Muneeb’s primary research interests encompass Pharmaceutical Nanotechnology, with a specific focus on nanoparticle applications in wound healing, biofilm-associated infections, and oncology. His work investigates innovative drug delivery systems and explores novel therapies for diabetes-related wound healing and other complex diseases.

Awards 🏆

Muneeb has been recognized with several prestigious awards, including the HEC-Indigenous Scholarship for his undergraduate studies and the Best Talent Award as part of the Prime Minister’s Laptop Scheme in Pakistan (2018). He was also awarded the Best Teacher Award at Billitong Higher Secondary School in 2020, highlighting his commitment to academic excellence.

Publications 📄

  • Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease
    • Authors: Safdar, M.; Ullah, M.; Hamayun, S.; Mustopa, A.Z.; Hasan, N.
    • Year: 2024
    • Citations: 1
  • Development of Clindamycin-Releasing Polyvinyl Alcohol Hydrogel with Self-Healing Property for the Effective Treatment of Biofilm-Infected Wounds
    • Authors: Alifah, N.; Palungan, J.; Ardayanti, K.; Yoo, J.-W.; Hasan, N.
    • Year: 2024
    • Citations: 0
  • 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease
    • Authors: Khan, M.A.; Khan, N.; Ullah, M.; Naeem, M.; Hasan, N.
    • Year: 2024
    • Citations: 4
  • Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease
    • Authors: Ullah, A.; Ullah, M.; Lim, S.I.
    • Year: 2024
    • Citations: 7
  • Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications
    • Authors: Khan, S.U.; Ullah, M.; Saeed, S.; Khan, M.A.; Lu, K.
    • Year: 2024
    • Citations: 4
  • Single-cell RNA Sequencing (scRNA-seq): Advances and Challenges for Cardiovascular Diseases (CVDs)
    • Authors: Khan, S.U.; Huang, Y.; Ali, H.; Ullah, M.; Lu, K.
    • Year: 2024
    • Citations: 7
  • A review of recent advances in nanotechnology for the delivery of therapeutics in wound healing
    • Authors: Ullah, A.; Ullah, M.; Lee, G.-J.; Lim, S.I.
    • Year: 2024
    • Citations: 0
  • Nutrition and Dietary Intervention in Cancer: Gaps, Challenges, and Future Perspectives
    • Authors: Zeb, F.; Mehreen, A.; Naqeeb, H.; Haider, A.; Naeem, M.
    • Year: 2024
    • Citations: 0
  • Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease
    • Authors: Safdar, M.; Ullah, M.; Wahab, A.; Awan, U.A.; Naeem, M.
    • Year: 2024
    • Citations: 7
  • Shaping the Future of Cardiovascular Disease by 3D Printing Applications in Stent Technology and its Clinical Outcomes
    • Authors: Ullah, M.; Bibi, A.; Wahab, A.; Saeed, S.; Hussain, T.
    • Year: 2024
    • Citations: 18

Conclusion 📝

With a robust academic background, hands-on research experience, and a strong publication record, Muneeb Ullah is a promising researcher in the field of pharmaceutical nanotechnology. His work not only advances wound healing therapies but also contributes to the broader understanding of drug delivery innovations. He is well-positioned to make impactful contributions to healthcare and nanomedicine in the years to come.